Literature DB >> 18583312

An experimental model of acute humoral rejection of renal allografts associated with concomitant cellular rejection.

Alice Bickerstaff1, Ronald Pelletier, Jiao-Jing Wang, Gyongyi Nadasdy, Nicholas DiPaola, Charles Orosz, Anjali Satoskar, Gregg Hadley, Tibor Nadasdy.   

Abstract

Acute humoral rejection (AHR), which occurs in up to 8% of kidney transplant recipients, is a significant cause of renal allograft dysfunction and loss. More efficacious treatment modalities are needed to eliminate or curtail alloantibody production and its deleterious effects on the kidney. The availability of animal models mimicking human AHR is essential to understand its pathophysiology and develop new treatment strategies. Using a mouse kidney transplant model, we demonstrate that presensitization of recipients with donor skin grafts results in rejection of subsequent renal allografts. All presensitized mice developed renal failure 8.6 +/- 4.3 days after engraftment, with serum creatinine values near 100 micromol/dl. Graft histology revealed mild, diffuse, interstitial, mononuclear cell infiltrates; prominent peritubular capillary inflammatory cell margination; patchy interstitial hemorrhage; interstitial edema; and focal glomerular fibrin deposition. Complement (C3d) deposition was diffuse and prominent in peritubular capillaries. Serum analysis demonstrated high levels of circulating alloantibodies with broad cross-reactivity to many MHC haplotypes. The clinical setting and histological findings of our model strongly resemble AHR, which is frequently associated with cellular rejection, a situation commonly encountered in human renal allograft recipients. This animal model provides a valuable tool to study the pathogenesis of AHR, its relationship to cellular alloimmunity, its contribution to graft injury, and the effects of various potential therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18583312      PMCID: PMC2475773          DOI: 10.2353/ajpath.2008.070391

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts.

Authors:  S R Lederer; B Kluth-Pepper; H Schneeberger; E Albert; W Land; H E Feucht
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

Review 2.  Acute humoral renal allograft rejection.

Authors:  Georg A Böhmig; Markus Exner; Bruno Watschinger; Heinz Regele
Journal:  Curr Opin Urol       Date:  2002-03       Impact factor: 2.309

3.  Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice.

Authors:  B A Wasowska; Z Qian; D L Cangello; E Behrens; K Van Tran; J Layton; F Sanfilippo; W M Baldwin
Journal:  Transplantation       Date:  2001-03-27       Impact factor: 4.939

4.  Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection.

Authors:  Alex B Magil; Kathryn Tinckam
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

5.  C4d deposition in acute rejection: an independent long-term prognostic factor.

Authors:  Andrew M Herzenberg; John S Gill; Ognjenka Djurdjev; Alex B Magil
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

6.  Murine renal allografts: spontaneous acceptance is associated with regulated T cell-mediated immunity.

Authors:  A A Bickerstaff; J J Wang; R P Pelletier; C G Orosz
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

7.  Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification.

Authors:  Shamila Mauiyyedi; Marta Crespo; A Bernard Collins; Eveline E Schneeberger; Manuel A Pascual; Susan L Saidman; Nina E Tolkoff-Rubin; Winfred W Williams; Francis L Delmonico; A Benedict Cosimi; Robert B Colvin
Journal:  J Am Soc Nephrol       Date:  2002-03       Impact factor: 10.121

8.  Acute humoral rejection of renal allografts in CCR5(-/-) recipients.

Authors:  A Bickerstaff; T Nozaki; J-J Wang; R Pelletier; G Hadley; G Nadasdy; T Nadasdy; R L Fairchild
Journal:  Am J Transplant       Date:  2008-03       Impact factor: 8.086

9.  Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.

Authors:  Lorraine C Racusen; Robert B Colvin; Kim Solez; Michael J Mihatsch; Philip F Halloran; Patricia M Campbell; Michael J Cecka; Jean-Pierre Cosyns; Anthony J Demetris; Michael C Fishbein; Agnes Fogo; Peter Furness; Ian W Gibson; Denis Glotz; Pekka Hayry; Lawrence Hunsickern; Michael Kashgarian; Ronald Kerman; Alex J Magil; Robert Montgomery; Kunio Morozumi; Volker Nickeleit; Parmjeet Randhawa; Heinz Regele; Daniel Seron; Surya Seshan; Stale Sund; Kiril Trpkov
Journal:  Am J Transplant       Date:  2003-06       Impact factor: 8.086

10.  Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities.

Authors:  Rui Pei; Jar-How Lee; Neng-Jen Shih; Mike Chen; Paul I Terasaki
Journal:  Transplantation       Date:  2003-01-15       Impact factor: 4.939

View more
  8 in total

1.  Adaptive immunity rather than viral cytopathology mediates polyomavirus-associated nephropathy in mice.

Authors:  J A Albrecht; Y Dong; J Wang; C Breeden; A B Farris; A E Lukacher; K A Newell
Journal:  Am J Transplant       Date:  2012-03-15       Impact factor: 8.086

2.  Key role for CD4 T cells during mixed antibody-mediated rejection of renal allografts.

Authors:  A Gaughan; J Wang; R P Pelletier; T Nadasdy; S Brodsky; S Roy; M Lodder; D Bobek; S Mofatt-Bruce; R L Fairchild; M L Henry; G A Hadley
Journal:  Am J Transplant       Date:  2014-01-10       Impact factor: 8.086

3.  Novel CD8 T cell alloreactivities in CCR5-deficient recipients of class II MHC disparate kidney grafts.

Authors:  Daisuke Ishii; Joshua M Rosenblum; Taiji Nozaki; Austin D Schenk; Kiyoshi Setoguchi; Charles A Su; Victoria Gorbacheva; William M Baldwin; Anna Valujskikh; Robert L Fairchild
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

4.  Allogeneic stimulation causes transcriptional reactivation of latent murine cytomegalovirus.

Authors:  M R Forster; A A Bickerstaff; J-J Wang; P D Zimmerman; C H Cook
Journal:  Transplant Proc       Date:  2009-06       Impact factor: 1.066

5.  In Vivo Attenuation of Antibody-Mediated Acute Renal Allograft Rejection by Ex Vivo TGF-β-Induced CD4+Foxp3+ Regulatory T Cells.

Authors:  Tao Liao; Youqiu Xue; Daqiang Zhao; Siwen Li; Mingyu Liu; Jingrong Chen; David Douglass Brand; Haofeng Zheng; Yannan Zhang; Song Guo Zheng; Qiquan Sun
Journal:  Front Immunol       Date:  2017-10-16       Impact factor: 7.561

6.  Alloimmunity But Not Viral Immunity Promotes Allograft Loss in a Mouse Model of Polyomavirus-Associated Allograft Injury.

Authors:  Steven C Kim; Jun Wang; Ying Dong; David V Mathews; Joshua A Albrecht; Cynthia P Breeden; Alton B Farris; Aron E Lukacher; Mandy L Ford; Kenneth A Newell; Andrew B Adams
Journal:  Transplant Direct       Date:  2017-05-12

7.  Mouse Model Established by Early Renal Transplantation After Skin Allograft Sensitization Mimics Clinical Antibody-Mediated Rejection.

Authors:  Daqiang Zhao; Tao Liao; Siwen Li; Yannan Zhang; Haofeng Zheng; Jing Zhou; Fei Han; Yu Dong; Qiquan Sun
Journal:  Front Immunol       Date:  2018-07-04       Impact factor: 7.561

8.  Experimental glomerular endothelial injury in vivo.

Authors:  George Haddad; Lin Fu Zhu; David C Rayner; Allan G Murray
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.